CHANGING CONCEPTS OF THE PATHOGENESIS OF WILSON'S DISEASE
Authors: J. M. WALSHE
Journal: Annals of Internal Medicine (1959)

Editorial1 November 1959CHANGING CONCEPTS OF THE PATHOGENESIS OF WILSON'S DISEASEJ. M. WALSHEJ. M. WALSHESearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-51-5-1110 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFor while the tired waves, vainly breaking, Seem here no painful inch to gain, Far back, through creeks and inlets, making, Comes silent flooding in the main.(Arthur Hugh Clough).Such is progress in medicine, it does not advance evenly upon a broad front but, here or there, surges swiftly forward as a growing point. The internist, daily battling with the more practical problems of care of the sick, inevitably gets left far behind the advancing front and, with the ever increasing volume of medical literature, he can scarce hope to recapture the lost ground. It is only by reading...1 Wilson SA: Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, Brain 34: 295, 1912. CrossrefGoogle Scholar2 Haurowitz F: Über eine Anomalie des Kupferstoffwechsels, Hoppe Seyler's Ztschr. f. physiol. Chem. 190: 72, 1930. CrossrefGoogle Scholar3 Lüthy F: Über die hepati-lentikülare Degeneration (Wilson-Westphal-Strümpell), Deutsche Ztschr. f. Nervenh. 123: 101, 1931. CrossrefGoogle Scholar4 Cumings JN: The copper and iron content of brain and liver in the normal and hepato-lenticular degeneration, Brain 71: 410, 1948. CrossrefMedlineGoogle Scholar5 PetersStockenThompson RALARH: British antilewisite: BAL, Nature, London 157: 837, 1946. Google Scholar6 Cumings JN: The effect of BAL in hepatolenticular degeneration, Brain 74: 10, 1951. CrossrefMedlineGoogle Scholar7 Denny-BrownPorter DH: The effect of BAL (2.3. dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease), New England J. Med. 245: 917, 1951. CrossrefMedlineGoogle Scholar8 HolmbergLaurell CGCB: Investigations in serum copper. II. Isolation of copper containing protein and description of some of its properties, Acta chem. Scand. 2: 550, 1948. CrossrefGoogle Scholar9 ThompsonWatson RHD: Serum copper levels in pregnancy and pre-eclampsia, J. Clin. Path. 2: 193, 1949. CrossrefGoogle Scholar10 CumingsGoodwinEarl JNHJCJ: Blood copper and its relationship to globulins, J. Clin. Path. 8: 69, 1955. CrossrefMedlineGoogle Scholar11 CartwrightHodgesGublerMahoneyDaumWintrobeBean GERECJJPKMMWB: Studies on copper metabolism. XIII. Hepatolenticular degeneration, J. Clin. Investigation 33: 1487, 1954. CrossrefMedlineGoogle Scholar12 MandelbroteStanierThompsonThurston BMMWRHMN: Studies on copper metabolism in demyelinating diseases of the central nervous system, Brain 71: 212, 1948. CrossrefMedlineGoogle Scholar13 Porter H: Copper excretion in the urine of normal individuals and of patients with hepatolenticular degeneration (Wilson's disease), Arch. Biochem. and Biophys. 31: 262, 1951. CrossrefMedlineGoogle Scholar14 ScheinbergGitlin IHD: Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease), Science 116: 484, 1952. CrossrefMedlineGoogle Scholar15 BearnKunkel AGHG: Biochemical abnormalities in Wilson's disease, J. Clin. Investigation 31: 616, 1952. Google Scholar16 LaheyGublerCartwrightWintrobe MECJGEMM: Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states, J. Clin. Investigation 32: 329, 1953. CrossrefMedlineGoogle Scholar17 Bearn AG: Genetic and biochemical aspects of Wilson's disease, Am. J. Med. 15: 442, 1953. CrossrefMedlineGoogle Scholar18 BearnKunkel AGHG: Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria, J. Clin. Investigation 33: 400, 1954. CrossrefMedlineGoogle Scholar19 GublerLaheyCartwrightWintrobe CJMEGEMM: Studies on copper metabolism. IX. The transportation of copper in blood, J. Clin. Investigation 32: 405, 1953. CrossrefMedlineGoogle Scholar20 Cartwright GE: Personal communication to the author (see 33). Google Scholar21 UzmanDenny-Brown LD: Aminoaciduria in hepatolenticular degeneration (Wilson's disease), Am. J. M. Sc. 215: 599, 1948. CrossrefMedlineGoogle Scholar22 UzmanIberChalmersKnowlton LPLTCM: The mechanism of copper deposition in the liver in hepato-lenticular degeneration (Wilson's disease), Am. J. M. Sc. 231: 511, 1956. CrossrefMedlineGoogle Scholar23 Uzman L: The intrahepatic distribution of copper in relation to the pathogenesis of hepato-lenticular degeneration, Arch. Path. 64: 464, 1957. Google Scholar24 Walshe JM: Hepatolenticular degeneration (Wilson's disease), Brit. M. Bull. 13: 132, 1957. CrossrefMedlineGoogle Scholar25 PorterFolch HJ: Brain copper protein fractions in the normal and in Wilson's disease, Arch. Neurol. and Psychiat. 77: 8, 1957. CrossrefGoogle Scholar26 UzmanHood LB: The familial nature of the aminoaciduria of Wilson's disease (hepatolenticular degeneration), Am. J. M. Sc. 223: 392, 1952. CrossrefMedlineGoogle Scholar27 SteinBearnMoore WHAGS: The aminoacid content of the blood and urine in Wilson's disease, J. Clin. Investigation 33: 410, 1954. CrossrefMedlineGoogle Scholar28 BearnKunkel AGHG: Localization of Cu 64 in serum fractions following oral administration: an alteration in Wilson's disease, Proc. Soc. Exper. Biol. and Med. 85: 44, 1954. CrossrefMedlineGoogle Scholar29 EarlMoultonSilverstone CJMJB: Metabolism of copper in Wilson's disease and in normal subjects. Studies with Cu 64, Am. J. Med. 17: 205, 1954. CrossrefMedlineGoogle Scholar30 OsbornWalshe SBJM: Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease, Lancet 1: 70, 1958. CrossrefMedlineGoogle Scholar31 Sass-KortsakSlaterGeigerCherniak ARJDGM: A study concerning the basic metabolic defect in Wilson's disease, Am. J. Dis. Child. 96: 540, 1958. Google Scholar32 Bearn AG: Wilson's disease: an inborn error of metabolism with multiple manifestations, Am. J. Med. 22: 747, 1957. CrossrefMedlineGoogle Scholar33 Walshe JM: Current views on the pathogenesis and treatment of Wilson's disease, Arch. Int. Med. 103: 155, 1959. CrossrefGoogle Scholar34 Walshe JM: Penicillamine, a new oral therapy for Wilson's disease, Am. J. Med. 21: 487, 1956. CrossrefMedlineGoogle Scholar35 FisterBouldingBaker WPJERA: The treatment of hepatolenticular degeneration with penicillamine, with report of 2 cases, Canad. M. A. J. 78: 99, 1958. MedlineGoogle Scholar36 Walshe JM: Studies on the action of penicillamine, to be published in Metal Binding in Medicine, J. B. Lippincott Company, Philadelphia. Google Scholar37 WalsheHill JMLE: Lancet 2: 444, 1959. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCopper balance studies during the treatment of patients with Wilson's disease�ber die Kupferausscheidung im Urin bei verschiedenen Krankheitszust�nden im KindesalterWilson's DiseaseEnzymic oxidation of the indole nucleus of 5-hydroxytryptamine: Properties of an enzyme in human serum and of the products of oxidation 1 November 1959Volume 51, Issue 5Page: 1110-1115KeywordsFloodingPathogenesis ePublished: 1 December 2008 Issue Published: 1 November 1959 PDF downloadLoading ...